Target Details
| UniProt AC | P00533 |
|---|---|
| Gene Symbol | EGFR |
| Protein Name | Epidermal growth factor receptor |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00757 (Furin-like) PF14843 (GF_recep_IV) PF07714 (PK_Tyr_Ser-Thr) PF01030 (Recep_L_domain) PF21314 (TM_ErbB1) |
Summary
- Multi-target molecules 3,433
- Clinical molecules 833
- Avg pChEMBL 7.29
KEGG Pathways (51)
- Adherens junction
- Bladder cancer
- Breast cancer
- Cadherin signaling
- Calcium signaling pathway
- Central carbon metabolism in cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Choline metabolism in cancer
- Colorectal cancer
- Coronavirus disease - COVID-19
- Cushing syndrome
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endocytosis
- Endometrial cancer
- Epithelial cell signaling in Helicobacter pylori infection
- ErbB signaling pathway
- Estrogen signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gap junction
- Gastric cancer
- Glioma
- GnRH signaling pathway
- HIF-1 signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human papillomavirus infection
- Integrin signaling
- JAK-STAT signaling pathway
- MAPK signaling pathway
- Melanoma
- MicroRNAs in cancer
- Non-small cell lung cancer
- Oxytocin signaling pathway
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Phospholipase D signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Relaxin signaling pathway
- Shigellosis
- Virion - Hepatitis viruses
Associated Diseases (12)
Active Molecules (3,433)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
IBZAELMPACLLJJ
|
8.1 | IC50 | 2 | — | |
WTWFBKFNVCFROY
|
8.1 | IC50 | 3 | — | |
XHJPFLSAHTYUNW
|
8.1 | IC50 | 2 | — | |
BARRZGQMKZYTJV
|
8.1 | IC50 | 2 | — | |
GRAAVPHBSRABFO
|
8.1 | IC50 | 2 | Yes | |
NOTKEBYHDOJLEM
|
8.1 | IC50 | 2 | — | |
QWAHCSOEUYGXDS
|
8.1 | IC50 | 4 | — | |
SXHXSFDRRRWGRB
|
8.1 | IC50 | 2 | — | |
YFFQYUIFTHZMHX
|
8.1 | IC50 | 2 | — | |
ABEGFBRZNZWQBS
|
8.1 | IC50 | 5 | Yes | |
ASEKFENKLHTYMI
|
8.1 | IC50 | 3 | Yes | |
AXVKGZLOECWENV
|
8.1 | IC50 | 2 | — | |
BKAWDVUEVXFMOR
|
8.1 | IC50 | 2 | — | |
BPGJJKMCXBBEBI
|
8.1 | IC50 | 2 | — | |
BVBMTEPFJRTLEL
|
8.1 | IC50 | 2 | — | |
CAZQZPUZMIOJCR
|
8.1 | IC50 | 2 | Yes | |
DBDQLLPCPIODHI
|
8.1 | IC50 | 5 | Yes | |
FIENMRUUADTWJC
|
8.1 | IC50 | 2 | Yes | |
FMSVVUDMNOXYTG
|
8.1 | IC50 | 2 | Yes | |
HOUMQZGBNXSVNG
|
8.1 | IC50 | 2 | — | |
IDQAZRHOHYFAOQ
|
8.1 | IC50 | 2 | Yes | |
IKUYEYLZXGGCRD
|
8.1 | IC50 | 3 | — | |
KDCWCHYNUNBAEU
|
8.1 | IC50 | 2 | — | |
KOQXIMMOAUHZFN
|
8.1 | IC50 | 2 | Yes | |
KOVLLCNIJRZXSU
|
8.1 | IC50 | 2 | — | |
LRPVMNFUGWCSFJ
|
8.1 | Ki | 2 | — | |
ORFZAATXNNRFKP
|
8.1 | IC50 | 2 | — | |
QDHHJTYWHXGEAY
|
8.1 | IC50 | 2 | — | |
QYRNHUOFBYAKEW
|
8.1 | IC50 | 2 | — | |
XMTCFSFHPPARKV
|
8.1 | IC50 | 2 | — | |
BQKAPRHCWWQTIM
|
8.1 | IC50 | 2 | — | |
GGLLZEGVMRMANJ
|
8.1 | IC50 | 13 | Yes | |
PEOYVSCYYMEJBB
|
8.1 | IC50 | 3 | Yes | |
ROHJEIACUNTGFP
|
8.1 | IC50 | 16 | — | |
HJPASCBASAXJFI
|
8.1 | IC50 | 2 | — | |
REGOTSLWVKSZRG
|
8.1 | IC50 | 2 | — | |
RVCKMZIQUFKZFD
|
8.1 | IC50 | 7 | — | |
CMWHBLTWQKOFFI
|
8.1 | IC50 | 2 | — | |
DVMHTSWRXUQGTL
|
8.1 | IC50 | 2 | — | |
VCYMOASGLMYUCI
|
8.1 | IC50 | 2 | — | |
ANOJHRBABLZKIY
|
8.1 | IC50 | 2 | — | |
DUEOFWOYVUMCKC
|
8.1 | IC50 | 3 | — | |
IXIJKXSIADDKHR
|
8.1 | IC50 | 12 | — | |
JPHUTKJINPEEPQ
|
8.1 | IC50 | 2 | Yes | |
RXIRGBATMPSFBO
|
8.1 | IC50 | 2 | — | |
WEKWLJJTCAFJDA
|
8.1 | IC50 | 2 | — | |
ZFRQPCBLXWLNAT
|
8.1 | IC50 | 2 | — | |
DUYJMQONPNNFPI
|
8.1 | IC50 | 11 | — | |
FZPKPBLYVQTKPP
|
8.1 | IC50 | 2 | — | |
IKVDAZUYVVSZPS
|
8.1 | IC50 | 2 | Yes |